EPISODE · Jul 26, 2022 · 33 MIN
Buying Public Companies
from M&A Science
Pranjal Gambhir, and Doretta Mistras, Managing Director - Global Investment Banking, Healthcare at Citi The M&A process varies when dealing with a public vs private company. To many, acquiring a public company is more ideal. First-time acquirers need to be aware of the differences between acquiring a public company and acquiring a private company. In this episode of the M&A Science Podcast, Pranjal Gambhir and Doretta Mistras, both Managing Directors, Global Investment Banking, Healthcare at Citi, talk about how to buy public companies. To check out Affinity's 2022 M&A Benchmark Report, download it for free at http://affinity.co/kison Liked today's episode? Unlock over 50 courses taught by top-tier M&A practitioners by joining the M&A Science Academy. Use code "podcast" on the sign-up page for a 20% discount, available on either monthly or annual plans. https://www.mascience.com/academy Want to learn about upcoming interviews, events, and industry trends? Sign up for our weekly newsletter. https://www.mascience.com/newsletter-signup If you're a head of corporate development and looking to build up a world-class M&A team, reach out to me at [email protected]. This episode is sponsored by FirmRoom, the fastest virtual data room used to get deals done. Leave the pay-per-page world behind by going to https://firmroom.com/
NOW PLAYING
Buying Public Companies
No transcript for this episode yet
Similar Episodes
Oct 3, 2025 ·28m
Sep 16, 2025 ·29m
Sep 16, 2025 ·47m
Sep 12, 2025 ·37m
Sep 11, 2025 ·40m
Sep 10, 2025 ·40m